Toth Financial Advisory Corp Acquires 4,846 Shares of CVS Health Co. (NYSE:CVS)

Toth Financial Advisory Corp increased its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 15.0% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 37,149 shares of the pharmacy operator's stock after acquiring an additional 4,846 shares during the period. Toth Financial Advisory Corp's holdings in CVS Health were worth $2,517,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in CVS. LaFleur & Godfrey LLC increased its position in CVS Health by 49.9% during the fourth quarter. LaFleur & Godfrey LLC now owns 4,836 shares of the pharmacy operator's stock worth $217,000 after acquiring an additional 1,610 shares during the period. Vest Financial LLC increased its holdings in CVS Health by 18.3% in the 4th quarter. Vest Financial LLC now owns 9,630 shares of the pharmacy operator's stock worth $432,000 after purchasing an additional 1,492 shares in the last quarter. Kingsview Wealth Management LLC boosted its position in CVS Health by 9.1% during the 4th quarter. Kingsview Wealth Management LLC now owns 184,634 shares of the pharmacy operator's stock worth $8,288,000 after buying an additional 15,400 shares during the period. Moloney Securities Asset Management LLC lifted its holdings in shares of CVS Health by 2.7% during the fourth quarter. Moloney Securities Asset Management LLC now owns 27,305 shares of the pharmacy operator's stock worth $1,226,000 after purchasing an additional 708 shares during the period. Finally, Empirical Finance LLC lifted its stake in shares of CVS Health by 17.8% in the fourth quarter. Empirical Finance LLC now owns 52,588 shares of the pharmacy operator's stock worth $2,361,000 after acquiring an additional 7,959 shares during the period. Institutional investors and hedge funds own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

CVS has been the topic of several research analyst reports. Truist Financial increased their target price on shares of CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Monday, May 12th. Royal Bank of Canada raised their price objective on shares of CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a report on Monday, May 5th. JPMorgan Chase & Co. increased their target price on shares of CVS Health from $80.00 to $81.00 and gave the company an "overweight" rating in a research report on Tuesday, February 18th. Wolfe Research upped their price objective on CVS Health from 67.00 to 70.00 and gave the company an "overweight" rating in a research note on Tuesday, February 11th. Finally, Cantor Fitzgerald raised shares of CVS Health from a "neutral" rating to an "overweight" rating in a report on Wednesday, February 12th. Two investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $74.75.

CVS Health Stock Up 0.8%

Shares of CVS stock opened at $63.61 on Monday. The stock's fifty day moving average price is $65.21 and its 200 day moving average price is $59.94. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $72.51. The company has a market cap of $80.47 billion, a price-to-earnings ratio of 17.38, a price-to-earnings-growth ratio of 0.98 and a beta of 0.56.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The company had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The firm's quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the business posted $1.31 EPS. On average, research analysts expect that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.18%. CVS Health's payout ratio is currently 63.48%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.